Author:
Urruticoechea Ander,Arnedos Monica,Walsh Geraldine,Dowsett Mitch,Smith Ian E.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717
2. Goldhirsch A, Gelber RD, Castiglione M (1990) The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group. Ann Oncol 1:183–188
3. Levine MN, Bramwell VH, Pritchard KI et al (1998). Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 16:2651–2658
4. Hortobagyi GN, Buzdar AU, Marcus CE et al (1986). Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr 1:105–109
5. Valagussa P, Moliterni A, Zambetti M, et al (1993) Long-term sequelae from adjuvant chemotherapy. Recent Results Cancer Res 127:247–255
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献